News & Analysis as of

Microsoft Pharmaceutical Patents

McDonnell Boehnen Hulbert & Berghoff LLP

AI News Roundup – USPTO’s Request for Comment, biopharma companies ban ChatGPT, OpenAI’s memory feature, and more

To help you stay on top of the latest news, our AI practice group has compiled a roundup of the developments we are following....more

Perkins Coie

Inter Partes Review Proceedings: A Third Anniversary Report

Perkins Coie on

When inter partes review (IPR) proceedings became effective in September 2012, few people would have predicted the transformative effect it would have on patents and the litigation landscape. Three years in, IPR has become...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide